NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03824405,"Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis",https://clinicaltrials.gov/study/NCT03824405,,COMPLETED,"This is a randomized, double-blind, vehicle-controlled, Phase 2 study in subjects with moderate AD.",YES,Atopic Dermatitis,DRUG: BTX 1204|DRUG: Vehicle,"Investigator's Global Assessment (IGA), Investigator's Global Assessment (IGA) success defined as an IGA score of ""Clear"" (0) or ""Almost Clear"" (1) with at least a 2-grade improvement, Day 85",,,Botanix Pharmaceuticals,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,200,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",BTX.2018.003,2019-02-04,2020-01-27,2020-03-04,2019-01-31,2022-08-31,2022-10-25,"Applied Research Center of Arkansas Inc., Little Rock, Arkansas, 72212, United States|T. Joseph Raoff MD Inc. / Encino Research Center, Encino, California, 91436, United States|Center for Dermatology Clinical Research, Fremont, California, 94538, United States|Dermatology Specialist Inc. - Murrieta, Murrieta, California, 92562, United States|Rady Childern's Hospital - San Diego, San Diego, California, 92123, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Precision Clinical Research, Davie, Florida, 33328, United States|Troy Sullivan, North Miami Beach, Florida, 33162, United States|DS Research, Louisville, Kentucky, 40241, United States|Delright Research, New Orleans, Louisiana, 70115, United States|Medisearch Clinical Trails, Saint Joseph, Missouri, 64506, United States|Washington Univerisy in St. Louis, Saint Louis, Missouri, 63141, United States|JDR Dermatology Research LLC, Las Vegas, Nevada, 89148, United States|The Acne Treatment and Research Center, Morristown, New Jersey, 07960, United States|Aventiv Research Inc - Dublin, Dublin, Ohio, 43016, United States|Greenville Dermatology, LLC, Greenville, South Carolina, 29607, United States|Dermresearch Inc, Austin, Texas, 78759, United States|J&S Studies Inc., College Station, Texas, 77845, United States|The Center for Skin Research at Suzanne Bruce & Associates Dermatology, Houston, Texas, 77056, United States|CMAX Clincial Research, Adelaide, 5000, Australia|BurwoodDermatology, Burwood, 6100, Australia|Sinclair Dermatology, East Melbourne, 3002, Australia|North Eastern Health Specialists, Hectorville, 5073, Australia|Premier Specialists PTY LTD, Kogarah, 2217, Australia|St George Dermatology & Skin Cancer Center, Kogarah, 2217, Australia|Captain Stirling Medical Centre, Nedlands, 6009, Australia|The Skin Hospital, Westmead, 2145, Australia|Veracity Clinical Research, Woolloongabba, 4102, Australia|Optimal Clinical Trials, Auckland, 1010, New Zealand|Clinical Trials New Zealand LTD, Hamilton, 3204, New Zealand|P3 Research, Wellington, 6021, New Zealand","Study Protocol, https://storage.googleapis.com/ctgov2-large-docs/05/NCT03824405/Prot_000.pdf|Statistical Analysis Plan, https://storage.googleapis.com/ctgov2-large-docs/05/NCT03824405/SAP_001.pdf"
